DIA Webinar with NextDocs and Microsoft to Provide Insight into Cloud-Based Regulatory Document Management Infrastructure

Share Article

DIA, in cooperation with NextDocs and Microsoft, will co-host the complimentary webinar “Moving Your Regulated Content Management Platform to the Cloud: Benefits & Barriers” on Sept. 17 from 1 p.m. to 2 p.m. EDT.

DIA Logo

DIA, in cooperation with NextDocs and Microsoft, will co-host the complimentary webinar “Moving Your Regulated Content Management Platform to the Cloud: Benefits & Barriers” on Sept. 17 from 1 p.m. to 2 p.m. EDT.

In response to market pressures on life science companies, a growing percentage of these companies are considering cloud-based solutions. These solutions provide the benefits of increased scalability, flexibility, and mobility options for regulated content management.

“A fast-growing number of life sciences companies are finding that the answer to increased market pressures lies in the utilization of an end-to-end solution that reduces IT complexity while maintaining flexibility, collaboration and scale. DIA’s widespread reach into the market is the perfect vehicle for effectively communicating the details of how Microsoft and NextDocs is delivering this solution,” said Matt Walz, MBA, Chief Strategy Officer, NextDocs Corporation.

These experts will define the significant benefits recognized by moving to a cloud-based regulatory document management infrastructure. Attendees will leave with strategies to integrate a cloud-based regulatory document platform in their own organization. In addition, you will be able to better evaluate the IT implications and investments needed for adoption of a cloud-based solution.

Register today for the webinar to learn from these experts:

Matt Walz, MBA, Chief Strategy Officer, NextDocs Corporation
Gabor Fari, Director of Business Development and Strategy, Microsoft Corporation

About DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA, and regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit http://www.diahome.org.

About NextDocs: NextDocs is a global leader in providing regulated content management and compliance solutions to life sciences organizations. NextDocs provides solutions for electronic trial master files (eTMF), regulatory submissions, standard operating procedures (SOP) and quality management systems (QMS). These solutions enable businesses in highly regulated industries to achieve compliance with the FDA and other agencies while automating processes, improving efficiency and dramatically reducing costs. NextDocs has delivered over 100 deployments with FDA regulated customers including five of the ten largest pharmaceutical companies and two of the largest clinical research organizations (CROs). NextDocs has won numerous awards including the Microsoft Life Sciences Partner of the Year award four years in a row. All NextDocs solutions are 100% browser-based and can be deployed in the cloud or on-premises. For more information visit http://www.nextdocs.com

About Microsoft: Founded in 1975, Microsoft is the worldwide leader in software, services, devices and solutions that help people and businesses realize their full potential.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robyn Mincher
DIA
+1 571.814.3367
Email >
DrugInfoAssn
Like >